Neutropenic sepsis is a significant infection following immunosuppression due to a low neutrophil count.
It is a common and predictable complication of bone marrow disorders and anticancer treatments, particularly chemotherapy.
The estimated incidence is 70-100%during the neutropenic phase after intensive cytotoxic therapy.
Neutropenic sepsis is a time-critical oncological emergency. It is the leading cause of non-relapse related mortality in patients with cancer undergoing intensive chemotherapy.
This module focuses on Neutropenic sepsis in adults secondary to cytotoxic anticancer treatments. Causes of neutropenic sepsis and the assessment and treatment of patients. The integral role of nurses who come in contact with patients with cancer in the identification and management of neutropenic sepsis.
At the end of this module participants will be able to:
